Recurrent mucosal leishmaniasis of the epiglottis in an immunosuppressed patient

Aronson, 2016, A diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH), Clin Infect Dis, 63, 202, 10.1093/cid/ciw670 Grech, 2020, Leishmania donovani mucosal leishmaniasis in Malta, BMJ Case Rep, 13, 10.1136/bcr-2020-237687 Garrido-Jareño, 2020, Cutaneous and mucocutaneous leishmaniasis: experience of a mediterranean hospital, Parasites Vectors, 13, 24, 10.1186/s13071-020-3901-1 Campino, 2010, Epidemiologia das leishmanioses em Portugal, Acta Med Port, 23, 859 Maia, 2014, Leishmaniasis in Portugal in the beginning of the XXI century, Saúde Glob e Doença Trop, v13 Darcis, 2017, Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy, BMC Infect Dis, 17, 478, 10.1186/s12879-017-2571-x N. Gilbert D., F Chambers H., S. Saag M., T. Pavia A., et al., 2021. Leishamaniasis. The Sanford guide to antimicrobial therapy 2021;App version 6.1.5. Moraes, 2012, Laryngeal leishmaniasis, Int Arch Otorhinolaryngol, 16, 523 Harms, 2003, Leishmaniasis in Germany, Emerg Infect Dis, 9, 7, 10.3201/eid0907.030023 Naucke, 2008, Sandflies and leishmaniasis in Germany, Parasitol Res, 103, 65, 10.1007/s00436-008-1052-y Al Balushi, 2018, Double Infection with Leishmania tropica and L. major in an HIV patient controlled with high doses of Amphotericin B, Open Forum Infect Dis, 5, ofy323, 10.1093/ofid/ofy323 Bourgeois, 2010, ‘Active chronic visceral leishmaniasis’ in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients, HIV Med, 11, 670, 10.1111/j.1468-1293.2010.00846.x